Abstract
For more than a decade, Kalorama Information has observed the successes and
failures of the IVD market. You can tap into this knowledge with this
authoritative guide.
As Kalorama Information has examined the markets for year, we have seen the
companies whose approaches have succeeded and those who have not been
successful. A small pivot in strategy often may have made the difference. We
have summed up this knowledge in What is Working in IVD: Successful
Commercialization of New Products and Technologies The report is written by
Kalorama' s lead diagnostic expert, Shara Rosen, R.T. M.B.A., author of six
best-selling editions of the industry' s leading market research report in IVD
diagnostics The Worldwide Market for In Vitro Diagnostic Tests. Rosen offers
tips gleaned from years of watching the market - keys to successful new
product launches in the industry as t is now.
In some ways diagnostics is a unique industry. To achieve commercial success,
IVD companies must earn the approval of several different groups, including
regulators, payer organizations, healthcare providers and physicians, all of
whom ultimately determine the value of a product and how well it will do in
the market. For that reason, strategic market-focused product development and
effective commercialization are crucial.
Rosen has developed a "six strengths approach" for companies engaging in
product commercialization, blending the solid marketing theory with the
realities of the diagnostics indusry:
- Strategic Market Planning, including: Pricing, Clinical Trial Information
Management, Distribution, The New Customer Segmentation and more
- Intellectual Property and Patent Protection, offers the basics of IP and
discusses whether to seek a partner.
- Regulatory Process Management , including: US, Europe, Japan, India, China
and more
- Reimbursement, looks at Trends, Past Successes and Failures, IVD and the
Obama Administration
- Product Life Cycle Management, how to Tell Your Story, Scale Up, Build a
Organizational Structure
- Market Forces Management, strategies for working with: Investors, the
Scientific Community, Consumers and more
It is estimated that there are several hundred new tests and test platforms in
development and near market. It is obvious that even if all of these devices
make it to market, not all will enjoy successful market penetration. With the
average cost to develop a new diagnostic test at least $100 - $200 million,
companies have little choice but to improve the efficiency of their research
and development and commercialization processes. Among other points, this
report will provide readers with the following information:
- How Time-Tested Marketing Techniques Can be Applied to Diagnostics
- What Can IVD Marketers Glean from the Success Stories of Major Players in
the Market
- How to Create a Successful Strategic Plan
- What Can IVD Marketers Learn from the Latest Customer Segmentation
Techniques?
- How to Use - and not to Use - Patents
- What Early Steps Marketers Can Take -- Even in the Clinical Trial Stage?
- How to Make Optimal Pricing Decision in Down Economic Times
Marketing mature products and of course new products and technologies is a mix
of art, intuition and marketing science. It involves a keen understanding of
the market parameters that you and your company can control - product design,
pricing, distribution options and of course sales training and promotions.
Companies also should invest in research that allows them to understand market
parameters that are totally not in their prevue to manage. These
uncontrollables include economic trends that may result in unexpected
obstacles and actions taken by competitors.
It is generally believed that consumer behavior is also a huge unpredictable
market parameter. This is where the art of marketing plays its most important
role. Well-designed investigative interactions between marketers and potential
consumers can provide a wide window into consumers' needs, perceptions and
capabilities to embark of purchase decisions.
This report blends marketing theory with actual events to provide clues on how
to implement marketing strategies appropriate for current market conditions
and for the future. Anyone launching a new product into the world diagnostic
market will benefit from this essential resource.
Table of Contents
EXECUTIVE SUMMARY
- Scope and Methodology
- Keys to Success
- INTRODUCTION
- Background
- Crucial Keys to Successful New Product Commercialization - Six Strengths
Model
- Point of View
Strength Point One - STRATEGIC PLANNING
- Clinical Trial and Information Management
- Qiagen/Digene
- Aspen Bio AppyScore
- AdvanDx PNA FISH test
- Epigenomics PRESEPT
- Genomic Health Oncotype DX
- Hologic
- Product Development
- PGxHealth
- Evidenced Based Medicine
- Pricing Challenges
- Down Economy Pricing Advice
- Five Steps to Value Pricing
- Pricing as an Impression
- Distribution Strategies
- Examples of IVD Distribution Arrangements
- Test Commercialization
- A New look at Customer Segmentation
- Finding "Buckets Within Buckets" of Customers
- Conclusion
Strength Point Two - MANAGING INTELLECTUAL PROPERTY
- Some IP and Patent Basics
- Barriers to Patent Protection
- Gene Patents
- To Partner Or Not
- Conclusion
Strength Point Three - MANAGING THE REGULATORY PROCESS
- Overview Of Regulatory Trends
- Multiplexed and Molecular Tests
- Regulatory Process by Region/Country
- United States
- European Economic Union
- Japan
- China
- India
Strength Point Four - ASSURING PRODUCT REIMBURSEMENT
- Reimbursement Issues and Strategies
- Governments React
- IVDs in Obama' s Healthcare World
- Wins and Disappointments
- Genomic Health
- Biosite/Inverness Medical Innovations
- Digene/Qiagen
- Conclusion
Strength Point Five - MANAGING THE PRODUCT LIFE CYCLE
- PR - Tell Your Story
- Scale-UP Issues
- Building a Supportive Organizational Structure
Strength Point Six - MANAGING MARKET FORCES
- Investors
- Venture Capital Activities in IVD
- Consumer Power
- Steps between Evaluation of Needs and a Purchase Decision
- Scientific/Medical Community
- Payer Groups
- Conclusion
